Showing results (301-310 of 2,886) with videos related to

Sort By:
Pageof 289
Expert Opinion on Investigational Drugs|May 2, 2003
The METHRO trialsAli Hamaad, Muzahir H Tayebjee, Gregory Y H Lip
Cerebrovascular Diseases (Basel, Switzerland)|July 28, 2021
Relationship between Chronic Kidney Disease, Time-in-Therapeutic Range, and Adverse Outcomes in Atrial Fibrillation: A post hoc Analysis from the AMADEUS TrialWern Yew Ding, Gregory Y H Lip, Alena Shantsila
Current Hypertension Reports|October 28, 2016
Effects of Aspirin on Endothelial Function and HypertensionMikhail S Dzeshka, Alena Shantsila, Gregory Y H Lip
Hypertension (Dallas, Tex. : 1979)|June 5, 2003
Pharmacological modulation of platelet function in hypertensionAndrew D Blann, Sunil Nadar, Gregory Y H Lip
The American Journal of Cardiology|September 11, 2007
Endotoxemia, inflammation, and atrial fibrillationChristopher J Boos, Gregory Y H Lip, Bernd Jilma
Journal of Thrombosis and Thrombolysis|June 19, 2007
The effects of coronary artery disease severity on time-dependent changes in platelet activation indices in stored whole bloodChristopher J Boos, Balu Balakrishnan, Gregory Y H Lip
Vascular Health and Risk Management|June 23, 2007
Management of atrial fibrillationPuneet Kakar, Christopher J Boos, Gregory Y H Lip
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|April 27, 2011
What are the costs of atrial fibrillation?Carina Blomstrom Lundqvist, Gregory Y H Lip, Paulus Kirchhof
Pageof 289